Building the infrastructure layerfor tech-enabled drug discovery

We are the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.

We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer.

Our vision is to make undruggable targets a thing of the past.

learn more
Select Investors
MicrosoftPlayground GlobalFoundersXY CombinatorScientia Ventures sam altman

As Seen In
ForbesScience MagazineEndpoints NewsBusiness InsiderWSJMicrosoft BlogTCGEN